Hangzhou Tigermed Consulting Co., Ltd
Research Hangzhou Tigermed Consulting Co., Ltd (3347.HK) on Bullrun: market cap HKD 34.61B, P/E 335.0, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3347.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyHKD
- Market capHKD 34.61B
- P/E335.0
- Dividend yield0.4%
- Financial periodQ2 2026
- RevenueCNY 1.91B
- Net income-CNY 462.20M
- Free cash flowCNY 52.41M
- Gross margin28.4%
Valuation Snapshot
latest market cap is HKD 34.61B; P/E is 335.0; dividend yield is 0.4%.
Peer valuation comparison
Latest P/E is 335x versus a Healthcare sector median of 21.69x (1444.3% above).
Latest dividend yield is 0.36% versus a Healthcare sector median of 2.41% (85.1% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 34.61B | 335.0 | 0.4% | 0.14 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.14 HKD, yield 0.4%.
About Hangzhou Tigermed Consulting Co., Ltd
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Hangzhou Tigermed Consulting Co., Ltd's market cap?
Hangzhou Tigermed Consulting Co., Ltd's market capitalization is HKD 34.61B.
What is Hangzhou Tigermed Consulting Co., Ltd's P/E ratio?
Hangzhou Tigermed Consulting Co., Ltd's price-to-earnings (P/E) ratio is 335.0.
Does Hangzhou Tigermed Consulting Co., Ltd pay a dividend?
Hangzhou Tigermed Consulting Co., Ltd has a dividend yield of 0.4%.
What does Hangzhou Tigermed Consulting Co., Ltd do?
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc.